BREITMEYER JAMES B

CIK 00012448235 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001244823

Recent Transactions

50 trades

Award
Oncternal Therapeutics, Inc.
Stock Option
2024-02-14+6,200→ 6,200 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2024-02-14+28,400→ 28,400 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2024-01-03$0.50/sh−50,955→ 443,034 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2024-01-03$0.50/sh−4,485→ 15,426 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+650,000→ 650,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−2,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−123,750→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+165,000→ 165,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−12,500→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+65,000→ 65,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−750,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+100,000→ 100,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+66,890→ 66,890 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−65,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−650,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−7,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+12,500→ 12,500 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−66,890→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+22,000→ 12,240 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−637,000→ 0 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−22,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+123,750→ 123,750 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+637,000→ 637,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+750,000→ 750,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−165,000→ 0 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+7,000→ 7,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02+2,000→ 2,000 total
Disposition to Issuer
Oncternal Therapeutics, Inc.
Stock Option
2023-10-02−100,000→ 0 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-07-03$0.36/sh−47,992→ 493,989 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-07-03$0.36/sh−4,007→ 19,911 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-14$0.29/sh+2,250→ 196,544 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-14$0.30/sh+47,750→ 194,294 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2023-04-13$0.29/sh+100,000→ 146,544 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+42,196→ 42,196 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+650,000→ 650,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2023-02-21+65,000→ 65,000 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-01-03$1.02/sh−1,325→ 23,918 total
Tax Payment
Oncternal Therapeutics, Inc.
Common Stock
2023-01-03$1.02/sh−27,793→ 541,981 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-07-28+123,750→ 123,750 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2022-07-28+12,500→ 12,500 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-07-28+18,750→ 25,243 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2022-07-28+185,625→ 569,774 total
Award
OTONOMY, INC.
Stock Option (right to buy)
2022-06-21+27,500→ 27,500 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−9,000→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−22,000→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−20,000→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−6,250→ 0 total
Disposition from Tender
ZOGENIX, INC.
Common Stock
2022-03-07−1,250→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−10,000→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−9,375→ 0 total

Companies

Recent Filings

Address

C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200

SAN DIEGO, CA, 92130

View on SEC.gov